Alphabet Inc.

Q2 2025 13F-HR Detailed Holdings

Location
Mountain View, CA
Holdings as of
6/30/2025
Date filed
8/1/2025
Form type
13F-HR
Num holdings
39
Total value ($000)
$2,135,230
Net value change ($000)
New positions
36
Sold out positions
0
Turnover %
100.0%
Sector allocation + QoQ delta (equities-only)

Holdings broken out by other managers reported in the original SEC filing. View aggregated holdings

You are on the SEC detailed breakdown page. Rows are shown as reported in the filing (including other manager, discretion, and voting authority fields), and are not merged like the standard holdings view. Switch to aggregated holdings.

Snapshot: Change Analysis

Compared to previous filing: —
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
ASTS 417,929
ARM 317,137
FRSH 241,641
PL 194,850
RVMD 152,063
Metsera, Inc. 141,162
Verve Therapeutics, Inc. 136,652
GTLB 122,912
TEM 98,557
DXCM 90,514
Top Reduces (Value $000, Stocks/ETFs)
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type Discretion Other Manager Sole Shared None

Other Managers

Num Name File Number
1 GV Management Company, L.L.C. 028-22704
2 Google LLC 028-22705
3 CapitalG II LP 028-22706
4 Verily Life Sciences LLC 028-22703
5 CapitalG III LP 028-23659